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Summary
Autoimmune diseases are characterized by highly specific immune responses against molecules
in self-tissues. Different autoimmune diseases are characterized by distinct immune responses,
making autoantibodies useful for diagnosis and prediction. In many diseases, the targets of au-
toantibodies are incompletely defined. Although the technologies for autoantibody discovery have
advanced dramatically over the past decade, each of these techniques generates hundreds of possi-
bilities, which are onerous and expensive to validate. We set out to establish a method to greatly
simplify autoantibody discovery, using a pre-filtering step to define subgroups with similar speci-
ficities based on migration of radiolabeled, immunoprecipitated proteins on sodium dodecyl sul-
fate (SDS) gels and autoradiography [Gel Electrophoresis and band detection onAutoradiograms
(GEA)]. Human recognition of patterns is not optimal when the patterns are complex or scat-
tered across many samples. Multiple sources of errors - including irrelevant intensity differences
and warping of gels - have challenged automation of pattern discovery from autoradiograms.
In this paper, we address these limitations using a Bayesian hierarchical model with shrinkage
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priors for pattern alignment and spatial dewarping. The Bayesian model combines information
from multiple gel sets and corrects spatial warping for coherent estimation of autoantibody signa-
tures defined by presence or absence of a grid of landmark proteins. We show the pre-processing
creates more clearly separated clusters and improves the accuracy of autoantibody subset detec-
tion via hierarchical clustering. Finally, we demonstrate the utility of the proposed methods with
GEA data from scleroderma patients.
Key words: Autoantibody signatures; Batch effect; Bayesian image registration; Clustering; Gel elec-
trophoresis; Peak detection; Markov chain Monte Carlo; Measurement error; Scleroderma.
1. Introduction
Discovering disease subgroups that share distinct disease mechanisms is fundamental to disease
prevention, monitoring and treatment. For example, in autoimmune diseases, specific autoimmune
responses are associated with distinct disease phenotypes and trajectories (Rosen and Casciola-
Rosen, 2016). Defining the molecular markers of these subgroups has value, as these markers are
of diagnostic and prognostic significance, and guide management and therapy. For example, an
immune response to RNA polymerase III in scleroderma is associated with cancer; this immune
response arises in response to a mutation in RNA polymerase III in that patient’s cancer. While
many prominent specificities recognized by the immune response have been defined, many remain
to be discovered. Although modern measurement technologies are revolutionizing the ability to
define specificities, each technique results in hundreds of possibilities, which are onerous and
expensive to validate. A simple technique identifies patterns of antibody reactivity based on the
abundance of different weighted antigens immunoprecipitated by patient sera. Defining similar
antibody reactivity patterns prior to applying one of the new discovery technologies would greatly
simplify validation and therefore reduce the cost and improve the speed of antigen identification.
To identify the autoantibodies present in a patient’s serum, scientists mix serum collected
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from each patient with radiolabeled lysates made from cultured cells. These lysates contain a
representation of all the proteins expressed in that cell type. Antibodies in each patients serum
recognize and bind tightly to the specific protein(s) in the lysate against which they are di-
rected (termed immunoprecipitation). After further processing, electrophoresis is used to sort
the immunoprecipitated mixture of molecules using a crosslinked polymer or gel that separates
the proteins by weight. Because different weighted molecules migrate with different speeds, the
sorted molecules form distinct autoradiographed bands along the gel. By design, one gel can sort
multiple samples on parallel lanes. Such experiments, referred to as gel electrophoresis autoradio-
graphy (GEA), serve to identify subsets that share one or more interesting observed bands. It is
noteworthy that the lysate proteins are present in their native conformation. In our experience,
many autoantibodies have epitopes that are conformationally dependent, giving GEA a powerful
advantage over many of the new peptide-based (linear epitopes) sequencing technologies. The
method in this paper is designed to estimate a multivariate binary autoantibody signature for
each sample that represents the presence or absence of autoantibodies over a grid of molecular
weights, referred to as landmarks.
To infer patient subsets, we can cluster patients based upon the presence or absence of each
band as well as other features of the radioactive intensities such as the peak scale and ampli-
tude. There are two critical barriers to the successful implementation of this approach that we
address. First, there are batch, or gel effects in the raw GEA data. By design, molecules of iden-
tical weight would migrate the same distance along the gel. This distance however varies by gel
due to differential experimental conditions. Second, gels are frequently slightly warped as they
electrophorese due to heating effects generated during the electrophoresis procedure and due to
artifacts introduced during physical processing of the gels. As the size and complexity of GEA
experiment database grow, the need for systematic, reproducible and scalable error correction
has also grown.
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In this paper, we introduce and illustrate a novel statistical approach to pre-process the high-
frequency GEA data which we show improve our ability to compare and cluster band patterns
across samples. The pre-processing involves peak detection and batch effect corrections. In par-
ticular, we propose a local scoring algorithm for peak detection that is computationally efficient
and performs well for minor peaks (Section 2.2). The detected peaks then enter the image align-
ment method that corrects batch effects in two steps: reference alignment and spatial dewarping.
First, reference alignment calibrates multiple gels towards a common molecular standard. We
perform piecewise linear stretching/compression by placing knots at the marker or reference
bands present on all the images (Section 2.3.1). The reference-aligned gel images produce a set of
peak locations that are then fitted by a novel hierarchical Bayesian model. The proposed model
assumes that the smooth spatial gel deformations have deviated the observed peaks from their
true landmarks. We use Markov chain Monte Carlo to estimate both the smooth warping func-
tions and, for each detected peak, the posterior probabilities over a grid of landmarks where it
is aligned. The Bayesian framework has the advantage of incorporating inherent uncertainty in
assigning a peak to a molecular weight landmark.
The aligned high-frequency intensity data (Section 3.2) may be the input of many methods
including hierarchical clustering, latent class models and factor analyses. In this paper, we focus
on illustrating the value of alignment for the standard hierarchical clustering applied to data with
known and unknown clusters (Section 4). At each iteration of the MCMC sampling, we obtain
the multivariate binary signatures that represent autoantibody presence or absence over a grid of
landmarks and align the gel images. Upon hierarchically clustering the aligned intensities at each
iteration, we obtain a collection of dendrograms. In particular, we use the standard correlation-
distance based agglomerative hierarchical clustering to create nested subgroups. For N samples,
hierarchical clustering produces a dendrogram that represents a nested set of clusters. Depending
on where the dendrogram is cut, between 1 and N clusters result. We demonstrate through real
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data that pre-processing more clearly separates the estimated clusters and improves the accuracy
of cluster detection compared to naive analyses done without alignment.
The rest of the paper is organized as follows. Section 2 introduces the importance of pre-
processing GEA data followed by algorithmic details for peak detection in Section 2.2 and batch
effect correction in Section 2.3. In Section 3, we describe model posterior inference by MCMC
and the statistical property of the shrinkage priors. We demonstrate how the proposed methods
function through an application to signature estimation and subgroup identification of sclero-
derma patients in Section 4. The paper concludes with a discussion on model advantages and
opportunities for extensions.
2. Data Pre-Processing
2.1 GEA Data and Pre-processing Overview
Gel electophoresis for autoantibodies (GEA) is designed to separate autoantibody mixtures ac-
cording to molecular weight and to radioactively map them as bands along the gel. Figure 1(a)
shows an example of a raw GEA image. We tested four sets of samples from scleroderma patients
with a malignancy; of note, these sera were pre-selected as being negative for the three most com-
monly found scleroderma autoantibodies (anti-topoisomerase 1, anti-centromere and anti-RNA
polymerase III antibodies, which in aggregate are found in about 60% of scleroderma patients).
Each sample set consisted of 19 patient sera plus one reference. In the middle panel of Figure
1(b), seven red vertical lines indicate the reference molecules of known weight (200, 116, 97, 66,
45, 31, 21.5) kDa. It also shows the band patterns that read out autoantibodies present in each
of 19 patient samples (lanes 2-20). The top of Figure 1(b) shows the intensities from all the
lanes; Seven clear spikes above the vertical lines again correspond to the reference molecules.
The bottom of Figure 1(b) shows the piecewise linear interpolation of the location-to-weight
function using the seven reference weights as knots. The weight of an arbitrary peak (“*”) can
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then be read from this interpolation. For example, the protein actin (about 42kDa) produced the
peaks immediately to the right of the 45kDa reference (the fifth vertical line from the left). The
misalignment of the actin peaks is caused by non-rigid image deformation (Section 2.3.2).
Identical reference molecules fail to align (empty circles, bottom panel of Figure 1(b)) across
multiple gels because of variation in experimental conditions such as the strength of the electric
field. We correct such misalignment by matching the reference peak locations across gels and then
piecewise-linearly stretch or compress each gel using the reference peaks as knots. The technique is
referred to as piecewise linear dewarping and was first used in human motion alignment anchored
at body joints (e.g., Uchida and Sakoe, 2001).
The autoradiographic process is also vulnerable to smooth non-rigid gel deformation. This is
most evident from the bands of actin, a ubiquitous protein of molecular weight 42 kDa, present in
all lanes at around 0.43 (middle panel of Figure 1(b)). The bands form a smooth curve from the
top to the bottom. The curvature represents the gel deformation since actin has identical weight
and should appear at identical locations across the 19 lanes. Without correction, this deformation
interferes with accurate sample comparisons even on the same gel. In Section 2.3.2, we propose
a Bayesian hierarchical image dewarping model with shrinkage priors to correct the deformation
and align the actin peaks.
To establish notations, let (t0,M0) =
{(
t0b ,M
0
gib
)}
represent the standardized, high-frequency
GEA data, for bin b = 1, . . . , B on lane i = 1, . . . , Ng from gel g = 1, . . . , G. Appendix S1 de-
scribes the standardization of raw data. Here t0 is a equi-spaced grid over the unit interval [0, 1],
where t0gb = b/B ∈ [0, 1], b = 1, . . . , B. M
0
gib is the radioactive intensity scanned at t
0
b for lane
i = 1, . . . , Ng, gel g = 1, . . . , G. Let N =
∑
gNg be the total sample size.
For the rest of this section, we take the high-frequency data (t0,M0) and map it to multivariate
binary data Y on a coarser common grid across gels. In Section 2.2, we propose a general method
to transform an arbitrary high frequency, nearly continuous intensity data into raw peak locations.
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We first apply the peak detection algorithm to (t0,M0) and obtain the peak locations P0. In
Section 2.3.1 we use the reference peaks, a subset in P0 from the first lane on each gel, to process
(t0,M0) into reference-aligned data (tR,MR). In Section 2.3.2, we transform the peaks P detected
from (tR,MR) to a joint posterior distribution of a N by L binary matrix Y that represents
presence or absence of a peak over a grid of L landmarks for all the N samples (L = 100 in our
application). In Section 3.2, we will process the reference-aligned high-frequency data (tR,MR)
into (t,M) where the peaks appear at the landmarks indicated by the ones in Y.
2.2 Peak Detection
This section presents a general algorithm for detecting peaks from intensity data. We illustrate
the algorithm by detecting peaks P0 from data (t0,M0). The peaks may appear with varying
background intensities. Because the occurrence of a local maximum is thought to be more impor-
tant than the background level in autoantibody signature estimation, we design the algorithm to
be insensitive to the absolute intensity level.
We adopted the following peak detection algorithm:
i. Local Difference Scoring. For each bin b = 1, . . . , B, lane i = 1, . . . , Ng of gel g = 1, . . . , G,
calculate the local difference score by comparing the intensity at bin b to its left and right
neighbors exactly h bins away and to the local minimum for locations in between (t−h, t+h)
(truncated at 1 or B if b is near the endpoints). That is, we calculate
scoregi(b) = sign
{
M0gib −M
0
gi,ℓ(b)
}
+ sign
{
M0gib −M
0
gi,r(b)
}
+
sign
{
M0gib − min
ℓ(b)≤b′≤r(b)
M0gib′ − C0
}
, (2.1)
where sign(a) = 1, 0,−1 indicates positive, zero, or negative values; ℓ(b) = max{b − h, 1}
and r(b) = min{b + h,B} denote the left and right neighbors h(= 10) bins away, and C0
denotes the minimum peak elevation. The tunning parameter h controls the locality of the
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peaks and C0 controls the minimum peak magnitude.
ii. Peak Calling. We look for the bins among peak candidates defined by {b | scoregi(b) = 3}
that maximize their respective local intensities (see Appendix S2 for details and alternative
peak calling methods). Let P0gi represent the collection of the peak locations for lane i and
gel g.
Remark 1: The score defined in (2.1) depends only on the signs of the differences in local
intensities. They can be computed in parallel across all the samples. A two-dimensional analogue
has been used in astrophysics to find low grey-scale intensity galaxies from telescope images (Xu
and others , 2016).
2.3 Batch Effect Correction
2.3.1 Reference Alignment via Piecewise Linear Dewarping. Molecules with identical weight
do not appear exactly at the same location in each lane of a single gel due to gel deformation or
across gels due to variations in experimental conditions. We first align the reference peaks P0g1,
g = 1, . . . , G via piecewise linear dewarping to address the gel-to-gel variation (Uchida and Sakoe,
2001). In our application, we used seven reference molecules of known weight (200, 116, 97, 66, 45, 31, 21.5)
kDa.
We first match the reference peaks P0g1 on a query gel g to the reference peaks Pg01 on the
template gel g0, and then use the matched reference peaks and the endpoints as knots to linearly
stretch or compress the gels. Quadratic or higher-order dewarping is also possible, but we found
linear dewarping performs sufficiently well for our data. Appendix S3 gives the details of the
algorithm. We denote the high frequency, reference aligned data by (tR,MR) = {(tRgib,M
R
gib)}.
Applying the peak detection algorithm in Section 2.2 to this data, we collect all the detected
peaks in P = {Pg, g = 1, . . . , G} where Pg represents the peaks from gel g.
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2.3.2 Bayesian Image Dewarping to Correct Gel Deformation. Another source of error during
autoradiographic visualization is the non-rigid, spatial gel deformation. The middle panel of
Figure 1(b) shows one such example. It also reveals three analytical challenges to be addressed
before obtaining meaningful results from an automatic disease subsetting algorithm. First, some
proteins, e.g., actin, are detected on multiple gels and must be aligned. The blue asterisks that
denote the detected peaks near 0.43, form a smooth but non-linear curve from the top to the
bottom of the gel. Second, fewer bands appear on the right half of the image, because these
smaller proteins tend to contain fewer methionine residues for radiolabeling. Higher estimation
uncertainty of the dewarping function is therefore expected for the right half. Third, the observed
locations of the peaks are likely random around their true locations as the result of the multiple
sources of error.
To address these issues, we designed a hierarchical Bayesian dewarping algorithm for two-
dimensional images. The algorithm simulates presence/absence data from the conditional dis-
tribution of protein occurrence over a grid of equi-spaced landmarks given the detected peaks
P from the prior pre-processing. The stochastic model is defined on a coarser grid of landmark
proteins, ν = {0 = ν0 < ν1 < . . . < νL < νL+1 = 1} where νℓ = ℓ/(L + 1), ℓ = 0, 1, . . . , L + 1.
In this paper, we will align peaks only to the internal knots {νℓ, ℓ 6= 0, L+ 1}; ν0 and νL+1 will
be used in the boundary constraint (2.5) to ensure endpoint alignment for all the sample lanes.
We introduce a novel shrinkage prior to promote alignment of peaks to a common landmark. We
also introduce shrinkage priors that regularize the overall smoothness of the spatial dewarping
functions.
Let (Tgij , ugij) denote the (location, lane number) for peak j = 1, . . . , Jgi on lane i = 1, . . . , Ng,
gel g = 1, . . . , G. We fix ugij to take values in {1, 2, . . . , Ng} and collect them in u = {ugij} where
ugij = ugi if they belong to the same lane i. Let Pg =
∑
i Jgi denote the total number of peaks
on gel g and P =
∑
Pg. Let T = {Tg}, where Tg = (. . . , Tgi1, Tgi2, . . . , Tgi,Jgi , . . .)
′ collects
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the peak locations for gel g = 1, . . . , G. Both u and T are P -dimensional column vectors. For
computational stability, without changing notation, we standardize T, u and ν by substract their
means and dividing by their standard deviations. We now use P = {T,u} to denote the data for
the Bayesian dewarping model.
Model Likelihood. Peak-to-landmark indicators Z. Let Zgij take values in {1, . . . , L}. For example,
Zgij = 3 indicates that the j-th peak in lane i on gel g is aligned to landmark 3. Let Z = {Zg, g =
1, . . . , G} where Zg = {Zgij , j = 1, . . . , Jgi, i = 1, . . . , Ng}. Note that any Z can be converted to
N multivariate binary observations Y = {(Ygiℓ, ℓ = 1, . . . , L)} for the presence or absence of a
landmark, where Ygiℓ = 1 {ℓ ∈ {Zgij , j = 1, . . . , Jgi}}, referred to as signature.
Gaussian mixture model for aligning observed peaks T. We model T as observations from a
Gaussian mixture model with L components, each representing one landmark. Given Z = {Zgij}
and the spatial dewarping function Sg to be discussed later, we assume
p
(Tgij = t︸ ︷︷ ︸peak
location
, ugi︸︷︷︸
lane
number
) | Zgij = ℓ︸ ︷︷ ︸
matched to
landmark ℓ
, Tgi,j−1︸ ︷︷ ︸
nearest left
peak location
, Sg︸︷︷︸
warping
function
, σǫ︸︷︷︸
noise
level
 =
{
φ (t;Sg(νℓ, ugi), σǫ) , t ∈ Igij(νℓ, A0);
0, otherwise,
(2.2)
ℓ = 1, . . . , L, for peak j = 1, . . . , Jgi, lane i = 1, . . . , Ng, gel g = 1, . . . , G, where φ(·; a, b) is the
Gaussian density function with mean a and standard deviation b, and Sg is an unknown smooth
bivariate function that characterizes the deformation (ν, u) 7→ (Sg(ν, u), u).
Remark 2: The peak location Tgij is assumed to follow a Gaussian distribution with mean
equal to νℓ plus a horizontal displacement Sg(νℓ, ugi) and noise level equal to σǫ. We assume
σǫ is independent of landmark and lane. The density function (2.2) is positive only in the set
Igij(νℓ, A0)
∆
= {t : |t− νℓ|< A0 and t > Tgi,j−1}. The first inequality prohibits Tgij being matched
to distant landmarks and limits the search space for Zgij in our algorithm; the second inequality
places order constraints on the observed peak locations Tgij > Tgi,j−1, j = 2, . . . , Jgi − 1. We will
restrict Zgij > Zgi,j−1 to avoid reverse dewarping.
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Bivariate smooth warping functions Sg. For gel g, we model the warping function Sg : R
2 → R
using the tensor product basis expansion
Sg(ν, u) =
Tν∑
s=1
Tu∑
t=1
βgstBg1s(ν)Bg2t(u), (2.3)
where Bg1s(·) and Bg2t(·) are the s-th and t-th cubic B-spline basis with intercept, and κν
and κu are the knots along the two coordinate directions, respectively (Friedman and others ,
2001, Chapter 5) and Tν and Tu are the total number of bases. In subsequent analyses, we
choose κν with Tν − 4 internal knots at the s/(Tν − 3)-th quantile of {Tgij}, s = 1, . . . , Tν − 4
and similarly for κu. Let the two sets of B-spline basis functions along ν- and u−direction be
Bg1(·) = (Bg11(·), . . . , Bg1Tν (·))
′ and Bg2(·) = (Bg21(·), . . . , Bg2Tu(·))
′, respectively.
However, valid spatial gel deformations are limited to gel stretching, compression or shift
along the ν direction. We thus constrain the shape of Sg, g = 1, . . . , G by
Monotonicity : ν0 ≤ Sg(ν, u) < Sg(ν
′, u) ≤ νL+1, ∀ν < ν
′, ∀u; (2.4)
Boundary Constraint : Sg(ν0, u) = ν0,Sg(νL+1, u) = νL+1. (2.5)
The first constraint prevents reverse gel dewarping and the second assumes no gel shifting.
It can be relaxed to allow horizontal shifts by adding/substracting ∆ for both equalities. We
implement both constraints by requiring the B-spline coefficients βg = {βgst} to satisfy: ν0 =
βg1t < βg2t < . . . < βg,Tν−1,t < βgTν t = νL+1, ∀t = 1, . . . , Tu. Although only sufficient for Sg’s
monotonicity and boundary constraints, the foregoing βg constraints allow flexible and realistic
warpings. Figure 2 shows a member warping function that corrects for local “L”-, “S”- and
“7”-shaped deformations.
The likelihood function (2.2) models the misaligned data P = {T,u} in terms of the unknown
spatial transformation Sg and the alignment Z. Multiple raw gel images are then aligned by the
model estimates accompanied by model-based uncertainty quantification. Importantly, coherent
image registrations must align the universal actin peaks and hence require the borrowing of
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information among multiple misaligned observations. We accomplish this by sharing a set of
intensity parameters {λℓ} among the gels.
Prior. Prior for Z. We describe a shrinkage prior for Z motivated by the need 1) to align the
actin peaks (middle panel, Figure 1(b)), and 2) to share the information about the location of
actin peaks across multiple gels.
We specify the prior distribution based on a discretized, non-homogeneous Poisson process
with extreme intensities at a small number of landmarks. Let the total number of the observed
peaks follow a Poisson distribution: Jgi
d
∼ Poisson(Λg), for sample i = 1, . . . , Ng, gel g = 1, . . . , G.
Given Jgi, let Z
∗
gij | {λ
∗
ℓ}
iid
∼ Categorical
(
{λ∗ℓ}
L
ℓ=1
)
describe which landmarks are present in
sample i of gel g. For sample lane i, we then define {Zgij} as the increasingly sorted {Z
∗
gij}. That
is, we impose the order restriction Zgij ≤ Zgij′ whenever peak j appears to the left of peak j
′
(Tgij ≤ Tgij′ ). For hyperpriors, let λ
∗
ℓ = λℓ/
∑L
ℓ′=1 λℓ′ where λℓ | τ
iid
∼ Normal(0, τ), ℓ = 1, . . . , L,
and the hyperparameter τ
d
∼ Inv-Gamma(10−4, 10−4). Integrating over τ , we obtain a marginal
t-distribution for λℓ.
Remark 3: It is easy to calculate the prior probability of landmark ℓ present in a sample
P(Ygiℓ = 1 | λ
∗
ℓ ) ≈ 1 − exp(−λ
∗
ℓ ), ℓ = 1, . . . , L, for large L. As shown by (A4) in Appendix, the
ratio of the conditional posterior probabilities of assigning the peak Tgij to landmark ℓ versus ℓ
′
is factorized into
φ(Tgij ;Sg(νℓ,ugi),σ)
φ(Tgij ;Sg(νℓ′ ,ugi),σ)
·
1−exp(−λ∗ℓ )
1−exp(−λ∗
ℓ′
) . Suppose landmark ℓ is associated with a higher
intensity, i.e., λ∗ℓ > λ
∗
ℓ′ , the second ratio favors landmark ℓ given the likelihood ratio in the first
term. Because the {λ∗ℓ} are independent of g and i, they globally modulate the probability of
a landmark being present in all the gels. In our application, all the landmarks are in a priori
assumed to be equally likely by specifying independent t-distributed priors for the λℓs. The t-
distributions are heavy-tailed and can occasionally generate a large value of λℓ0 . Given λℓ0 , the
posterior sampling algorithm will visit and then retain any configuration of Z that results in a
large value of
∑
g,i Ygiℓ0 if the configuration substantially increases the joint posterior.
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Prior for βg. We incorporate the prior knowledge that large and abrupt image deformations are
rare. We first specify priors for the horizontal basis coefficients βgst, s = 2, . . . , Tν − 1 at the
u-direction basis t = 1. We use a first-order random walk prior (Lang and Brezger, 2004)
βgst − β
id
s
d
∼ N
(
·;βg,s−1,t − β
id
s−1, σ
−2
g1
)
1 {βgst ∈ (βg,s−1,t, νL+1)} , t = 1, s = 2, . . . , Tν − 1, (2.6)
where βid = (βid1 , . . . , β
id
Tν
)′ is the vector of coefficients to represent an identity function I : ν 7→ ν
in terms of the bases {Bgs1(·)}
Tν
s=1; The truncation of βgst is needed for monotonicity (2.4). The
hyperparameter σ2g1 controls the similarity between {βgs1}
Tν
s=1 and β
id and hence the similarity
between Sg(·, u) and the identity function I; σ
2
g1 = 0 represents no warping. We refer to σ
−2
g1 as
the smoothing parameter along the ν-direction.
Next, for any s = 2, . . . , Tν − 1, we specify another random walk prior for the vertical basis
coefficients
βgst
d
∼ N
(
·;βgs,t−1, σ
−2
gs
)
1{βgst ∈ (βg,s−1,t, νL+1)}, t = 2, . . . , Tu. (2.7)
Similarly, the hyperparameter σ−2gs controls the smoothness of Sg along the vertical or u− di-
rection; σ2gs = 0 produces identical amounts of warping for all the lanes. Details about the
hyperpriors for {σ2gs, s = 1, 2, . . . , Tν − 1} are provided in Appendix S4.
Joint Distribution. The joint distribution of all the unknowns is
G∏
g=1
{ Ng∏
i=1
[ Jgi∏
j=1
N
(
Tgij ;Bg1(νZgij )
′βgBg2(ugi), σ
−2
ǫ
)
1{Tgij ∈ Igij(νZgij , A0)}︸ ︷︷ ︸
likelihood (2.2)
× Jgi!
Jgi∏
j=1
Categorical(Zgij ;λ)1{Zgij ≤ Zgi,j+1, j = 1, . . . , Jgi − 1}
]
︸ ︷︷ ︸
prior of Z
× NTν−1
(
{βgs1}
Tν−1
s=1 ;β
id
[−Tν ]
, σ−2g1 ∆
′
1∆1
)
1{ν0 = βg11 < . . . < βgs1 < . . . < βg,Tν−1,1 < νL+1} · p(σ
2
g1)︸ ︷︷ ︸
prior (2.6) and hyperprior of the smoothing parameter
×
Tν−1∏
s=2
[
NTu
(
βgs•;0, σ
−2
gs ∆
′
2∆2
)
1{ν0 = βg1t < βg,s−1,t < βgst < νL+1, ∀t ≥ 2} · p(σ
2
gs, ρg)
]
︸ ︷︷ ︸
prior (2.7) and hyperpriors of the smoothing parameters
}
p(λ),(2.8)
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where p(λ), p(σ2g1) and p(σ
2
gs, ρg) are the priors and hyperpriors and Nd(·;µ,Λ) denotes the d-
dimensional multivariate normal density with mean µ and precision matrixΛ (can be degenerate).
The matrix ∆1 maps a column vector to its first-order differences (used in 2.6): ∆1kk′ = δ(k +
1, k′) − δ(k, k′), k = 1, . . . , Tν − 2, k
′ = 1, . . . , Tν − 1, where δ(a, b) = 1 if a = b and equals 0
otherwise; Similarly we define ∆2 with Tν replaced by Tu + 1.
3. Model Estimation and Implementation
3.1 Posterior Sampling
We use Markov chain Monte Carlo (MCMC) to simulate samples from the joint posterior dis-
tribution of all the unknowns (e.g., Gelfand and Smith, 1990) and then draw posterior infer-
ences about chosen functionals of the model parameters. Of special interest are the gel warp-
ing functions {Sg(·, ·;β)} and the peak-to-landmark alignment Z. Appendix S5 describes the
sampling algorithm and discusses conditions for statistical identifiability of the warping func-
tions. All the model estimation and visualization are performed by the R package spotgear
(https://github.com/zhenkewu/spotgear).
Turning to dewarping a new GEA image g∗, we perform reference alignment (Section 2.3.1)
and then obtain the peaks Pg∗ (Section 2.2). We approximate the joint posterior of (βg∗ ,Zg∗) by
p(βg∗ ,Zg∗ | P ,Pg∗) =
∫
p(βg∗ ,Zg∗ | λ,Pg∗)p(λ | P ,Pg∗)dλ ≈
∫
p(βg∗ ,Zg∗ | λ,Pg∗)p(λ | P)dλ,
where the first term of the integrand is an one-sample conditional posterior and the second term
is the posterior of λ given the old peaks P . Given Pg∗ , the first term can be derived from the joint
distribution (2.8) with G = 1. The integral can then be approximated by K−1
∑
k p(βg∗ ,Zg∗ |
λ(k),Pg∗) where {λ
(k), k = 1, . . . ,K} are the stored posterior samples.
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3.2 Exact Peak Alignment for M
We now describe the high-frequency data (t,M) = (t,M(Z)) that have peaks exactly aligned
according to Z. We simply perform piecewise linear dewarping for each sample lane so that the
detected peak (Tgij , ugi) is horizontally adjusted to match its landmark νZgij , j = 1, . . . , Jgi.
To do so, we apply the algorithm in Appendix S3 with {ν0, Tgi1, . . . , TgiJgi , νL+1} as a query
and
{
ν0, νZgi1 , . . . , νZgiJgi , νL+1
}
as a template. In the following analyses, we will create aligned
data using either 1) Z = Z(k), k = 1, . . . ,K, the stored MCMC samples when calculating the
posterior distributions of the parameters that are functions of Z, or 2) Z = Ẑ := {Zˆgij =
argmaxℓ=1,...,L p(Zgij = ℓ | P)}, the maximum a posteriori (MAP) alignment to obtain M(Zˆ).
Remark 4. Because Sg is monotonic in ν given u, let S
−1
g (·;u) denote its inverse. One might be
tempted to dewarp the images so that (t, u) is horizontally aligned to
(
S−1g (t;u), u
)
. However,
because a peak Tgij varies around its mean Sg(νZgij ), unless σ
2
ǫ = 0, the inverse mapping cannot
guarantee that S−1g (Tgij ;ugi) is equal to νZgij .
4. Applications to Scleroderma Patient Subsetting
Our methodology is motivated by the long-term clinical objective of finding an autoantibody sig-
nature that subsets autoimmune disease patients into groups with more homogeneous phenotypes
and disease trajectories. The first step is to use the GEA data to cluster patients into subgroups
with potential to have different outcomes. We used sera from well-characterized patients with
scleroderma and an associated cancer identified through the IRB-approved Johns Hopkins Scle-
roderma Center database (Shah and others , 2017). To test our algorithms, we first analyze two
GEA replicates each of 20 samples. Compared to the results of hierarchical clustering without
pre-processing, we show our pre-processing method creates more clearly separated clusters. We
also show our pre-processing improves the accuracy of cluster detection evaluated against the
true matching. As a second test, we apply the pre-processing method to GEA measurements on
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76 patients with unknown clustering. We observe that the use of the pre-proecessing algorithm
identifies clusters that are clearly separated and scientifically meaningful.
4.1 Outline of Analyses
For subsequent analyses, this section describes the steps of pre-processing, clustering and three
metrics that evaluate the obtained clusters.
Pre-processing. We apply the peak detection algorithm in Section 2.2 followed by batch effect
corrections as described in Section 2.3. We exclude the reference lane on each gel when performing
the two dimensional Bayesian dewarping. We used Tν = 10 and Tu = 6 cubic B-spline basis
functions in the horizontal and vertical directions, respectively. The dewarping functions are
estimated by {Sˆg = Sg(·, ·; βˆg)} where βˆg is the posterior mean estimated by the empirical
average of the MCMC samples. We also obtain the MAP estimate Ẑ = {Zˆgij}. The choice
of the number of bases is crucial for the estimation of the warping functions (e.g., Lang and
Brezger, 2004). For example, larger values of (Tν , Tu) define a richer class of functions that can
accommodate abrupt local image deformations. Visual inspection of the alignment of the actin
peaks makes clear that more parsimonious models are preferred. Further improvements in knot
selection is possible using knots on a nonequidistant grid so that more knots are placed where
the spatial image warping is severe and the peaks are dense.
Clusterings. Given the peak-to-landmark alignment Z, we follow Section 3.2 to obtain peak-
aligned images M = M(Z) and then obtain clustering solutions. For example, let M = M(Zˆ)
where Zˆ is the MAP alignment. For each pair of sample i and i′, we calculate the pairwise distances
d(i, i′) = 1 − ĉor(Mgi·,Mgi′·) where Mgi· = (Mgi1, . . . ,MgiB)
′ and ĉor(·, ·) is the Pearson’s
correlation coefficient. Denote the N by N matrix of pairwise distances by Dˆ = {d(i, i′)}. We
use Dˆ in the standard agglomerative hierarchical clustering with complete linkage to produce a
dendrogram T̂ = T (Dˆ). By varying the level of cutting the dendrogram T̂ , we obtain a nested
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set of clusterings Cˆ(n), n = 2, . . . , N . We similarly denote the dendrogram produced without
pre-processing by T̂ 0 = T (D0) where D0 is the correlation-based distance matrix computed from
M
0. We denote the nested clusters by Cˆ0(n), n = 2, . . . , N . We will evaluate the obtained clusters
by three criteria below.
Adjusted Rand Index. We assess the agreement between two clusterings of the identical set of
observations using the adjusted Rand index (aRI; Hubert and Arabie (1985)). aRI is defined by
aRI(C, C′) =
∑
r,c
(
nrc
2
)
−
[∑
r
(
nr·
2
)∑
c
(
n·c
2
)]
/
(
N
2
)
0.5
[∑
r
(
nr·
2
)
+
∑
c
(
n·c
2
)]
−
[∑
r
(
nr·
2
)∑
c
(
n·c
2
)]
/
(
N
2
) , (4.9)
where nrc represents the number of observations placed in the rth cluster of the first partition
C and in the cth cluster of the second partition C′,
∑
r,c
(
nrc
2
)
(≤ 0.5
[∑
r
(
nr·
2
)
+
∑
c
(
n·c
2
)]
) is
the number of observation pairs placed in the same cluster in both partitions and
∑
r
(
nr·
2
)
and∑
c
(
n·c
2
)
calculates the number of pairs placed in the same cluster for the first and the same
cluster for second partition, respectively. aRI is bounded between −1 and 1 and corrects for
chance agreement. It equals one for identical clusterings and is on average zero for two random
partitions; larger values indicate better agreements between the two clustering methods.
Average silhouette. We also evaluate the strength of each clustering method using the average
silhouette (Rousseeuw, 1987). For observation i, its silhouette s(i) for a partition C compares
the within- to the between-cluster average distances: s(i) = [b(i) − a(i)]/max{a(i), b(i)} where
a(i) is the average distance of i to all other observations within the same cluster and b(i) =
minC∈C:i/∈C
∑
i′∈C
d(i,i′)
|C| is the minimum average distance between i and a cluster not containing
i. s(i) lies in [−1, 1] where a large value indicates observation i is in a tight and isolated cluster.
A larger average silhouette s¯(C) = N−1
∑
i s(i) indicates more clearly separated and tighter
clustering C.
Confidence levels of clusters. In addition to the alignment uncertainty addressed by the posterior
distribution [Z | P ], another source of uncertainty is the clustering of the aligned high-frequency
intensity data (t,M(Z)) given Z. In this paper we chose not to specify the full probability dis-
18 Z. Wu and others
tribution for the continuous intensities (t,M(Z)). Following Shimodaira and others (2004) and
Efron and others (1996), we use bootstrap resampling to assess the confidence in the estimated
dendrogram T̂ (setting Z = Ẑ, the MAP). The bootstrap method perturbs the data by randomly
sampling the columns of (t,M(Ẑ)) with replacement and assesses the confidence levels for the
presence of each subtree in T̂ . We calculate the frequency with which a subtree appears in an esti-
mated dendrogram across all the bootstrap iterations where a large value (e.g., > 0.95) indicates
strong evidence. We similarly bootstrap (t0,M0) to assess the confidence in the dendrogram T̂ 0
estimated without alignment.
4.2 Replication Experiments
Each of 20 biological samples were tested with two different lengths of exposure to autoradio-
graphic devices: long (two-week) versus short (one-week) exposure. We ran 40 lanes on two gels
that form 20 replicate pairs. Each gel image has 20 sample lanes: 19 serum sample lanes plus one
reference lane comprised of molecules with known weights. The posterior dewarping results are
shown in Appendix Figure S2.
We assess the agreement between the estimated clustering Cˆ(k)(n) and the true replication-
based clusters C∗ by aRI(Cˆ(k)(n), C∗), for the number of clusters n = 2, . . . , 20 and the stored
MCMC iteration k = 1, . . . ,K. At iteration k, Cˆ(k)(n) is the clustering solution obtained by
cutting the dendrogram that hierarchically clusters the peak-matched data M(Z(k)) where Z(k)
is drawn from the posterior [Z | P ].
The pre-processing enhances the hierarchical clustering to produce clusters closer to the true
replicate pairs. In Figure 3, the posterior mean of the adjusted Rand indices based on K =
5, 000 saved MCMC samples (solid line, K−1
∑
k aRI(Cˆ
(k)(n), C∗)) are uniformly higher than the
adjusted Rand indices based on data without pre-processing (dashed line, aRI(Cˆ0(n), C∗)). In the
bottom panel, for every n, the posterior distribution for the difference between the two aRIs
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excludes zero increases with the numbers of clusters. In addition, the pairwise distances in Dˆ
(obtained from M(Ẑ)) decreased by between 6.2 and 66.4% (mean 26.9%) relative to those in
D0. These decreases in the distances result in a dendrogram T̂ that puts 13 replicate pairs at the
terminal leaves as compared to 8 in T̂ 0.
We also observed uniformly increased confidence levels of the presence of true replicate pairs
upon pre-processing. Appendix Figure S3 examines the confidence levels associated with each sub-
tree with (hierarchically clustering the MAP-aligned data
(
t,M(Ẑ)
)
) and without pre-processing.
For example, for pair 18, the estimated confidence level increases from 0.71 to 1 after pre-
processing; The confidence levels for detecting the pairs 2, 8 and 11 see similar increases from
0.67, 0.79, 0.66 to 0.97, 0.86, 1, respectively. The increase in confidence levels is partly explained by
the tighter clusters obtained after data pre-processing: the average silhouette computed from the
MAP clustering, s¯
(
Cˆ(n)
)
, increased 14.2− 117.6% (0.03− 0.18 in magnitude) for n = 2, . . . , 20
clusters.
4.3 Scleroderma GEA Data without Replicates
We ran 4 GEA gels, each with 19 patient sera and one reference lane. The sera are from sclero-
derma patients with cancer who are all negative for common autoantibodies to RNA polymerase
III, topoisomerase I and centromere proteins. We had no other prior knowledge about known or
novel autoantibodies at the time the study was conducted. The sera were loaded in random order
on each gel; the reference sample comprised of known molecules was always in the first lane. In
the following, we describe the estimated dewarping, alignment and the resulting clusters.
Dewarping. We pre-process the four gel sets by estimating the dewarping functions {Sg, g =
1, 2, 3, 4} and the peak-to-landmark alignment Z. We first removed a few spots on the right of
the gels caused by localized gel contamination and assumed absence of peaks at these spots.
The posterior dewarping results are shown in Figure 4. Each detected peak {Tgij} (blue dot) is
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connected to its matched MAP landmark Zˆgij (red triangle). The vertical bundle of black curves,
one per landmark, visualizes the global shape of the estimated warping functions Sˆg. Along each
estimated vertical curve, the locations
{(
Sˆg(νℓ, u), u
)
, ∀u
}
represent identical molecular weights.
Alignment to landmarks. The marginal posterior probabilites of each landmark in a sample are
shown at the bottom of Figure 4. For example, the posterior probability is 0.59 for landmark 50
(about 43.4 kDa, actin): the MAP estimate Zˆ shows that 73 out of 76 lanes. The marginal posterior
probability is expected to further increase when more samples containing actin are analyzed via
hierarchical Bayesian dewarping. Landmark 46 (about 46.6 kDa) is another autoantibody hotspot
where 54 out of 76 lanes have matched peaks. On the other hand, only 18 and 1 out of 76 are
matched to Landmarks 36 (about 59.8 kDa) and 89 (about 23.4 kDa), respectively. Their marginal
posterior probabilities are hence low at 0.21 and 0.01.
An animation of the continuous dewarping process is available at https://github.com/
zhenkewu/spotgear. It matches the detected peaks Tgij to their MAP landmarks Zˆgij and
morphs the posterior mean dewarping Sˆg into the constant function I : (ν, u) 7→ (ν, u). Also
shown is the pre-processed high-frequency data (t,M(Zˆ)) with exactly matched peaks as de-
scribed in Section 3.2.
Clusters. Our pre-processing method removed global warping phenomena and revealed a few
strong clusters. The clusters with 0.95 confidence levels or higher are shown in red boxes in
Figure 5 for the analyses done with pre-processing (top) and without pre-processing (bottom).
A comparison of the two clustering solutions favors the pre-processing approach. For example,
within the dendrogram at the top, the first cluster from the right (number 44) consists of seven
sample lanes ((Set, Lane): (1,19), (4,3), (1,18), (3,8), (4,10), (2,4), (2,13)) that are enriched at
roughly 32.7 and 27.9 kDa. This group is split into two clusters (numbers 47 and 14) for the
analyses done without pre-processing. In a second example, the cluster 46 at the bottom and
cluster 40 at the top are comprised of identical samples (enriched at about 103.4 kDa). We
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observe the confidence level increases from 0.97 to 1 after pre-processing. Pre-processing again
produced more clearly separated clusters and eliminated many large clusters that are otherwise
formed at the bottom of Figure 5; We observed 8.8 − 39.5% increases in the average silhouette
based on the MAP alignment.
5. Discussion
In this article, we have developed a novel statistical approach to pre-processing and analyzing
two-dimensional image data obtained from gel electrophoresis autoradiography (GEA). Our ob-
jective is to eliminate artifactual data patterns that can confound our ability to use standard
clustering algorithms such as hierarchical clustering to detect subsets of autoimmune disease
patients. The hierarchical Bayesian image dewarping model provides a natural framework for
assessing uncertainty in the estimated alignment and warping functions and allows us to make
inferences about many functions of parameters.
In Section 4, we analyzed two sets of data from scleroderma patients. For the data with
replication, we showed that the adjusted Rand indices increased if we perform pre-processing
prior to standard hierarchical clustering. Based on the MAP alignment, the average silhouette that
measures the strength of clustering increased by 14 to 118%. The pre-processing also increased
the confidence levels for detecting true replicates.
For the data without replicates, we showed that our pre-processing method successfully aligned
the actin peaks. It also increased the confidence levels for the clusters that appeared in both
clusterings (one with pre-processing and the other without pre-processing).
We conclude that there is added benefits of applying the pre-processing procedure prior to
estimating disease subsets. We expect marginal though worthwhile gains to be achievable by
using more carefully designed and tested tuning parameter selection procedure for local scoring
(Section 2.2).
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In the analysis of data with out replicates (Section 4.3), we grouped the samples by creating
a single dendrogram given a fixed Z = Zˆ, i.e., the MAP alignment. Uncertainty exists in both
the alignment and the dendrogram obtained by hierarchical clustering. We have addressed the
former by the posterior distribution [Z | P ] and the latter by bootstraping. Future work is needed
to assume a likelihood involving the unknown dendrogram structure to obtain and represent its
posterior uncertainty (e.g., Chakerian and Holmes, 2012).
Two extensions based on prior biological knowledge are the current subject of further research.
First, in our hierarchical Bayesian dewarping model, we assumed that the intensity parameters
{λ∗ℓ} are shared among the samples. However, the prevalence of autoantibodies may differ by
subpopulation. For example, cancer versus non-cancer patients may have distinct distributions
for the abundance of certain autoantibodies. We can either add another hierarchy on top of
{λ∗ℓ} or develop regression models for {λ
∗
ℓ} to incorporate disease phenotype information and
covariates such as age and gender.
Second, proteins in the cells tend to work in complexes, so multiple autoantibodies are likely
to be produced against a particular protein complex. This mechanism can be represented by a
binary matrix EC×L where the c-th row (Ec1, . . . , EcL) is a multivariate binary vector with 1
for presence of landmark ℓ in complex c and 0 otherwise. The complexes are then assembled
via ηN×L = AE to produce the actual presence or absence of the landmarks for every patient,
where A is a N × C binary matrix where each row represents the presence or absence of the C
complexes. Prior biological knowledge can be readily implemented via constraints on A or E.
For example, Ai1 = 1 for all the samples acknowledges the universal presence of autoantibodies
produced against complex 1, e.g., actin and likely others. A and E can be inferred from the
alignment indicators Y and continuous intensities. We may use regularization or shrinkage priors
in a Bayesian framework to encourage a few maximally different complexes (e.g., Broderick and
others , 2013). One practical advantage of the Bayesian factorization approach lies in its convenient
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accommodation of repeated GEA on the same unknown sample by placing equality constraints
on the rows of A. Finally, our latent variable formulation η = AE makes it easy to incorporate
multiple sources of patient lab and phenotype data that inform η, facilitate subgroup definition
by A and perform individual predictions via the posterior predictive distributions of η (e.g.,
Coley and others , 2016; Wu and others , 2016, 2017).
Supplementary Materials
Supplementary Material is available at http://biostatistics.oxfordjournals.org.
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Fig. 1: Gel electrophoresis autoradiography data for 20 samples on one gel. a) Raw GEA image. b) Top:
Radioactive intensities for all the samples; Middle: Heatmap of the radioactive intensities for all the
samples. The blue asterisks (∗) denote the detected peaks. Seven vertical red lines indicate the locations of
the seven reference molecules observed on lane 1. Bottom: Actual molecular weights (Y-axis) as read from
the location along the gel (X-axis). Four location-to-weight curves are shown here, each corresponding to
reference lane 1s in the four gels analyzed in Section 4.3 (the dashed red curve “- - -” is for the gel shown
in the middle). Note the reference molecule misalignment shown by the scattered “©”.
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Fig. 2: The posterior mean estimate of a gel warping function S that corrects local stretching or
compression. Highlighted are three vertical smooth curves, each of which aligns the peaks (blue
asterisks “∗”) with identical molecular weights.
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Fig. 3: Comparison between the adjusted Rand Indices obtained with and without pre-processing.
Top: The solid line and the blue shaded area represent the posterior mean aRIs and the pointwise
95% credible intervals, respectively. The dashed line is based on M0 without pre-processing.
Bottom: The solid line represents the difference between the aRIs obtained with and without
pre-processing: {K−1
∑
kaRI(Cˆ
(k)(n), C∗) − aRI(Cˆ0(n), C∗), n = 2, . . . , 20}; the shared area shows
the pointwise 95% credible intervals.
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